oberschleissheim, december 17, 2014 in addition to glass containers, pharmaceutical manufacturers are increasingly using primary containers made of plastics. in the case of soft plastics, there is a risk of migration. schreiner medipharm develops customerspecific, low migration labels for plastic containers that do not compromise the medicines contained in them. therefore, special adhesive systems, materials, and inks were qualified to develop the ideal label design for each particular plastic container. unbreakable, costeffective, convenient increasingly, primary containers made of plastics are used in the pharmaceutical industry. however, soft plastic materials have a drawback molecules from solvents and other substances contained in inks, adhesives, and film materials might possibly migrate through the packaging over the years. for example, eye drops in soft plastic bottles might be contaminated or their effectiveness impaired. to ensure that harmless materials are used for each particular label design, schreiner medipharm conducted a study with a renowned, independent test institute to analyze, calculate, and evaluate the migration tendency of various label compositions. the results make it possible to specifically develop low migration label solutions for each application, without any major expenditure of time or investment by the pharmaceutical manufacturer. furthermore, the use of verifiably harmless low migration labels increases the probability of a smooth approval from the respective drug administration authorities and ideally the approval process can be shortened.
